Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

479 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Electroconvulsive therapy disrupts functional connectivity between hippocampus and posterior default mode network.
Gbyl K, Labanauskas V, Lundsgaard CC, Mathiassen A, Ryszczuk A, Siebner HR, Rostrup E, Madsen K, Videbech P. Gbyl K, et al. Among authors: siebner hr. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Jun 8;132:110981. doi: 10.1016/j.pnpbp.2024.110981. Epub 2024 Feb 17. Prog Neuropsychopharmacol Biol Psychiatry. 2024. PMID: 38373628 Free article.
Executive Control and Associated Brain Activity in Children With Familial High-Risk of Schizophrenia or Bipolar Disorder: A Danish Register-based Study.
Johnsen LK, Larsen KM, Fuglsang SA, Ver Loren van Themaat AH, Baaré WFC, Madsen KS, Madsen KH, Hemager N, Andreassen AK, Veddum L, Greve AN, Nejad AB, Burton BK, Gregersen M, Eichele H, Lund TE, Bliksted V, Thorup AAE, Mors O, Plessen KJ, Nordentoft M, Siebner HR. Johnsen LK, et al. Among authors: siebner hr. Schizophr Bull. 2023 Sep 26:sbad134. doi: 10.1093/schbul/sbad134. Online ahead of print. Schizophr Bull. 2023. PMID: 37756493
Changes in weight, body composition and metabolic parameters after switch to dolutegravir/lamivudine compared with continued treatment with dolutegravir/abacavir/lamivudine for virologically suppressed HIV infection (The AVERTAS trial): a randomised, open-label, superiority trial in Copenhagen, Denmark.
Pedersen KBH, Knudsen A, Møller S, Siebner HR, Hove JD, Gerstoft J, Benfield T. Pedersen KBH, et al. Among authors: siebner hr. BMJ Open. 2023 Aug 21;13(8):e075673. doi: 10.1136/bmjopen-2023-075673. BMJ Open. 2023. PMID: 37604629 Free PMC article. Clinical Trial.
479 results